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Abstract 13 
Accumulating evidences suggest that viruses hijack cellular proteins to circumvent the 14 
host immune system. Ubiquitination and SUMOylation are extensively studied 15 
post-translational modifications (PTMs) that play critical roles in diverse biological 16 
processes. Crosstalk between ubiquitination and SUMOylation of both host and viral 17 
proteins has been reported to result in distinct functional conses1quences. Enterovirus 18 
71 (EV71), an RNA virus belonging to Picornaviridae family, is a common cause of 19 
hand, foot and mouth disease. Little is known concerning how host PTM systems 20 
interact with enteroviruses. Here, we demonstrated that the 3D protein, an 21 
RNA-dependent RNA polymerase (RdRp) of EV71, is modified by small 22 
ubiquitin-like modifier-1 both during infection and in vitro. Residues K159 and 23 
L150/D151/L152 were responsible for 3D SUMOylation determined by bioinformatic 24 
prediction combined with site-directed mutagenesis. And primer-dependent 25 
polymerase assays indicated that mutation of SUMOylation sites impaired 3D 26 
polymerase activity and virus replication. Moreover, 3D is ubiquitinated in a 27 
SUMO-dependent manner, and SUMOylation is crucial for 3D stability which may be 28 
due to the interplay between the two PTMs. Of importance, increasing the level of 29 
SUMO-1 in EV71-infected cells augmented the SUMOylation and ubiquitination 30 
level of 3D, leading to enhanced replication of EV71. These results together 31 
suggested that SUMO and ubiquitin cooperatively regulated EV71 infection either by 32 
SUMO-ubiquitin hybrid chains or by ubiquitin conjugating to the exposed lysine 33 
residue through SUMOylation. Our study provides a new insight into how a virus 34 
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utilizes cellular pathways to facilitate its replication.  35 
  36 
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Importance 37 
Infection with Enterovirus 71（EV71）often causes neurological diseases in children 38 
and EV71 is responsible for the majority of fatalities. Based on a better understanding 39 
of interplay between virus and host cell, antiviral drugs against enteroviruses may be 40 
developed. As a dynamic cellular process of post-translational modification, 41 
SUMOylation regulates global cellular protein localization, interaction, stability, and 42 
enzymatic activity. However, little is known concerning the SUMOylation directly 43 
influence virus replication by targeting viral polymerase. Herein, we found that EV71 44 
polymerase 3D was SUMOylated during EV71 infection and in vitro. Moreover, the 45 
SUMOylation sites were determined. And in vitro polymerase assays indicated that 46 
mutations at SUMOylation sites could impair polymerase synthesis. Importantly, 3D 47 
is ubiquitinated in a SUMOylation-dependent manner which enhances the stability of 48 
the viral polymerase. Our findings indicate that the two modifications likely 49 
cooperatively enhance virus replication. Our study may offer a new therapeutic 50 
strategy against virus replication.  51 
52 
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Introduction 53 
Small ubiquitin-like modifier (SUMO) modification, a member of post-translational 54 
modifications (PTMs), is important for the regulation of many cellular proteins and 55 
pathways (1). SUMO represents a novel protein modifier similar to the well-studied 56 
ubiquitin. Structural analysis revealed high similarities between the two PTMs despite 57 
limited (18%) sequence identity (2). Four SUMO isoforms exist in vertebrates with 58 
each having an approximate molecular mass of 12 kDa. SUMO-2 and SUMO-3 can 59 
form polymeric SUMO chains via a single, conserved lysine residue (3, 4). Without 60 
such site, SUMO-1 cannot act as a linkage to elongate chains in vivo but as a chain 61 
terminator on poly-SUMO-2, 3 chains (5-7). 62 
Similar to ubiquitination, SUMO proteins are initially synthesized as inactive 63 
precursors and cleaved by a specific protease belonging to the family of 64 
sentrin-specific proteases (SENPs) to expose the COOH-terminal diglycine motif (8). 65 
The carboxyl terminus of mature SUMO peptide is linked to a cysteine residue in 66 
E1-activating enzyme (SUMO-activating enzyme, SAE1/SAE2) via a thioester in an 67 
ATP-dependent manner. The activated SUMO is subsequently transferred to a 68 
cysteine residue of the SUMO-conjugating enzyme Ubc9. Although Ubc9 can transfer 69 
SUMO to the target protein, mutual action of Ubc9 and E3 SUMO ligases is required 70 
for an efficient modification (9-11). An isopeptide bond is formed between the lysine 71 
residue of the target protein and SUMO. The modification is dynamically reversible. 72 
In addition to its role in SUMO precursor maturation, SENPs also act as SUMO 73 
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deconjugation enzymes to complete the SUMO modification (SUMOylation) cycle 74 
(8).  75 
Typically, the lysine in the amino acid consensus motif ψ-K-X-D/E or inverted motif 76 
E/D-X-K-ψ (ψ represents a large hydrophobic residue) of a protein is recognized as 77 
SUMOylation site (6, 12, 13). Apart from covalent modification, target proteins may 78 
be modified non-covalently via SUMO-interacting motifs (SIMs) (6, 12). In general, 79 
the SIMs contain a hydrophobic core (V/I-x-V/I-V/I or V/I-V/I-x-V/I/L), flanked by 80 
acidic residues either upstream or downstream (14-17). In addition to being 81 
structurally related, ubiquitin and SUMO modification of substrates are preferentially 82 
occurring on lysine residues, and ubiquitin can be hybridized with SUMO moiety by 83 
anchoring to the lysine on poly-SUMO (18, 19). Crosstalk between the two PTMs 84 
may be involved in genome stability and cell growth, which are associated with 85 
pathogen resistance and cancer treatment (20). Studies indicate that SUMOylation can 86 
antagonize ubiquitin/proteasome mediated degradation by competing the same lysine 87 
to stabilize the target protein or cooperatively degrade the target protein by sharing the 88 
same lysine with ubiquitin (20, 21).  89 
Viruses, as obligate pathogenic organisms, must usurp the host proteins and cellular 90 
pathways throughout their life cycles to evade antiviral defenses by creating an 91 
environment that facilitates their replication (7). Many viral proteins have been 92 
identified as substrates for SUMOylation. Viruses can interact with and exploit the 93 
enzymes of the SUMO pathways to promote their assembly, replication, or to evade 94 
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the host immune system. Viruses could also be constrained by the host SUMO 95 
systems and vice versa (22). Some viruses possess more than one SUMOylated 96 
proteins, indicating the complexity of virus-host interactions. For instance, 97 
SUMOylation of cytomegalovirus (HCMV) DNA polymerase subunit UL44, and 98 
immediate-early 1 and 2 proteins (IE1 and IE2) are required for an efficient viral 99 
replication (23-26). At least five influenza virus proteins are SUMO targets, and the 100 
infection of influenza virus leads to a global increase in cellular SUMOylation (27). 101 
SUMOylation of NS1 accelerates virus growth; M1 protein SUMOylation facilitates 102 
viral ribonucleoprotein export and the assembly of virus particles; and NP protein 103 
SUMOylation regulates the intracellular trafficking of NP and efficient virus 104 
production (28-30). The early lytic gene product (K-bZIP), the major transcriptional 105 
factor (K-Rta), and the latency-associated nuclear antigen 2 of Kaposi’s 106 
sarcoma-associated herpesvirus are SUMOylated to achieve an efficient viral 107 
replication (31-33). SUMOylation of the p6 domain of Gag polyprotein and integrase 108 
of human immunodeficiency virus type 1 are important for virus replication (34, 35). 109 
Nevertheless, SUMOylated viral proteins from other viruses remain to be discovered. 110 
A global study of viruses and host SUMOylation will enhance our understanding of 111 
the interactions between viruses and the host. 112 
EV71 belongs to the Enterovirus genus (human Enterovirus A) of the Picornaviridae 113 
family, which causes severe neurological diseases in young children under five years 114 
old, known as hand, foot and mouth disease (36). Similar to other human Enterovirus, 115 
including Poliovirus, Coxsackie virus, and Echovirus, EV71 is a single-stranded RNA 116 
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virus with a single open reading frame encoding a precursor protein. After infection, 117 
the precursor is cleaved into four structural (VP1, VP2, VP3, and VP4) and seven 118 
nonstructural (2A, 2B, 2C, 3A, 3B, 3C, and 3D) proteins (37). The 3D protein is a 119 
RNA-dependent RNA polymerase (3Dpol) and responsible for the process of RNA 120 
replication. 3C protease is SUMOylated at lysine residue 52 (K52) by SUMO-1. 121 
SUMOylation of 3C increases ubiquitination, which leads to the degradation of 3C 122 
and eventually causes the reduction of viral replication (38). Our bioinformatic 123 
analysis suggested that EV71 3D polymerase is likely to be SUMOylated and may 124 
contain both covalent and non-covalent motifs. However, whether 3D is indeed 125 
SUMOylated and the role of such modification during the infection remain to be 126 
addressed.  127 
In the present study, we demonstrated that EV71 3D is modified by SUMO-1 both in 128 
vivo and in vitro. We further identified K159 and 150-152 SIM as the sites for 129 
SUMOylation. Mutations at both SUMOylation sites impaired polymerase synthesis 130 
in in vitro polymerase assays. In addition, we found that the K63-linked ubiquitin 131 
modification of 3D is SUMOylation-dependent, and a combination of the two 132 
modifications resulted in higher 3D stability and enhanced viral replication. Although 133 
SUMOylation of 3C and 3D resulted in opposite effects on virus reproduction, 134 
enhanced EV71 replication in SUMO-1-elevated cells indicates that 3D SUMOylation 135 
plays a predominant role. Our findings together imply that EV71 exploits host cellular 136 
modification for effective replication, revealing a potential target for antiviral therapy. 137 
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Materials and methods 138 
Cell culture and virus manipulation 139 
Human embryonic kidney cells (HEK 293T) (China Center for Type Culture 140 
Collection, CCTCC) and African green monkey kidney epithelial cell (Vero, CCL-81, 141 
American Type Culture Collection) were cultured in Dulbecco’s Modified Eagle 142 
Medium. Human rhabdomyosarcoma cell (RD, CCL-136, American Type Culture 143 
Collection) were grown in Minimal Essential Medium. All cells were maintained in 144 
medium containing 10 % fetal bovine serum (Life Technology, Australia) in 5 % CO2 145 
at 37 °C.  146 
EV71 BrCr strain was obtained from the Institute of Medical Biology, Chinese 147 
Academy of Medical Science (39). Virus titers were measured by 50 % tissue culture 148 
infectious dose (TCID50) in RD cells using the Reed–Muench formula (40). One step 149 
growth curve of viruses were determined with parental EV71 at a desired multiplicity 150 
of infection (MOI) (41). EV71 infectious clone was kindly provided by Minetaro 151 
Arita (National Institute of Infectious Diseases, Tokyo, Japan) (42). EV71 infectious 152 
clone and its mutant recombinant RNAs were in vitro transcribed by RiboMAX 153 
large-scale RNA production system-T7 kit (Promega) (43). The RNAs were 154 
transfected into Vero cells to rescue EV71 wild-type and mutant viruses, and these 155 
viral strains were amplified in RD cells (39). 156 
Antibodies and reagents 157 
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EV71 3D, 3C, and VP1 polyclonal antibodies were prepared by immunizing rabbits 158 
with His tag-3D, 3C, and VP1 fusion proteins, respectively. Rabbit anti-hemagglutinin 159 
(HA) and mouse anti-V5 antibodies were purchased from CoWin Biotech (Beijing, 160 
China). Mouse anti-β-actin antibody was acquired from Proteintech (Wuhan, China). 161 
Rabbit anti-SUMO-1, 2, and 3 antibodies were purchased from Cell Signaling 162 
Technology (Beverly, MA, USA). Mouse monoclonal anti-flag M2 and mouse 163 
anti-HA antibodies were purchased from Sigma–Aldrich (St Louis, MO). Mouse 164 
anti-myc, mouse monoclonal anti-Ub, and mouse control IgG were obtained from 165 
Abmart (Shanghai, China), Santa Cruz (CA, USA), and Boster (Wuhan, China), 166 
respectively. MG132, a proteasome inhibitor, and complete protease inhibitor cocktail 167 
were purchased from Calbiochem (San Diego, CA, USA) and Roche (Roche, 168 
Indianapolis, IN), respectively. N-Ethylmaleimide (NEM) and cycloheximide (CHX) 169 
were obtained from Sigma-Aldrich. Western and IP lysis buffer and RIPA lysis buffer 170 
were purchased from Beyotime (Jiangsu, China). 171 
Plasmid construction 172 
Flag-3D and HA-3D were generated by inserting EV71 3D coding sequence into 173 
pCAGGS as previously described (44, 45). All the mutations of 3D (K159R, 174 
L150A/D151A, L150A/D151A/L152A, K159R/L150A/D151A/L152A, 175 
V263A/S264A/L265A, and I317A/D318A/L319A) were created by overlapping 176 
extension PCR. Recombinant EV71 harboring 3D mutations were constructed by 177 
overlapping extension PCR using the infectious clone as a template at indicated sites. 178 
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The verification of the mutants was performed by RNA extraction, reverse 179 
transcription and PCR (39). 180 
pcDNA3-HA-SUMO-1 was obtained from Junying Yuan (Addgene plasmid 21154) 181 
(46). SRa-HA-SUMO-2, pcDNA3/HA-SUMO-3, and Flag-SENP-1 were gifts from 182 
Edward Yeh (Addgene plasmid 17360, 17361, and 17357) (47, 48). pCMV hUbc9 wt 183 
HA was a gift from Peter Howley (Addgene plasmid 14438) (49). 184 
pcDEF-HA-SUMO-1, pcDEF-Myc-Ubc9, and pcDEF-Flag-SUMO-2 were 185 
generously provided by Hong Tang (Wuhan Institute of Virology, Chinese Academy 186 
of Sciences, Wuhan, China) (50). pRK-Flag-SUMO-2 was kindly provided by Yanyi 187 
Wang (Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China) 188 
(51). Myc-SUMO-1 and V5-SENP-1 were constructed by inserting SUMO-1 and 189 
SENP-1 coding sequences into pCAGGS, respectively. Flag-SUMO-1, 2, and 3 were 190 
created by amplifying and inserting their coding sequences into pCAGGS. 191 
HA-K48-Ub and HA-K63-Ub were mutants of HA-Ub with all lysine residues 192 
mutated into arginines, except K48 and K63 (52). HA-UB-(KO) was a mutant of 193 
ubiquitin created by the substitution of lysine residues Lys63 of HA-K63-Ub with 194 
arginine. 195 
The plasmid expressing wild-type (WT) 3D was generated by cloning the 3D gene 196 
into a pET26-Ub vector (53, 54), and the 3D K159R, K159A, and L150A/D151A 197 
mutants were further constructed using the WT plasmid as the template. 3D was 198 
cloned into pGEX-6p-1 (GE Healthcare) to produce GST-tag 3D. pSUMO-1 199 
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containing SUMO-activating enzyme E1 (SAE1 and SAE2) was from Primo Schär 200 
(Addgene plasmid 52258) (55). His-tag in pSUMO-1 was substituted with Strep-tag 201 
to create a pSUMO-1-Strep. 202 
Protein preparation and in vitro polymerase assays 203 
The plasmids for the expression of WT 3D and its variants were transformed into 204 
Escherichia. coli strain BL21 (DE3) (pCG1) (kindly supplied by Dr. Craig Cameron) 205 
for expression (54). The bacteria were cultured and purified as described previously, 206 
except that the induction condition before harvesting was 11 h at 25 °C (56). The 207 
preparation of the 33-nucleotide RNA template (T33) was as described previously (57, 208 
58). The 10-nucleotide RNA primer (P10) was purchased from Integrated DNA 209 
Technologies. The T33/P10 construct was annealed at 45 °C for 3 min at a molar ratio 210 
of 1:0.9 in an RNA annealing buffer (RAB) (50 mM NaCl, 5 mM Tris [pH 7.5], 5 mM 211 
MgCl2). A typical 20 µl reaction mixtures containing 6 µM 3D or its mutants, 50 mM 212 
Tris [pH 7.0], 20 mM NaCl, 55 mM KCl, 5 mM MgCl2, 4 mM TCEP 213 
(tris-[2-carboxyethyl]phosphine), 300 µM ATP, 4 µM (T33/P10) construct and 300 214 
µM GTP were incubated at 22.5 °C for 15, 30, or 60 min before being quenched by an 215 
equal volume of stop solution (95 % [vol/vol] formamide, 20 mM EDTA [pH 8.0], 216 
0.02 % [wt/vol] bromphenol blue, and 0.02 % [wt/vol] xylene cyanol). The quenched 217 
samples were heated at 100 °C for 3 min. The RNA species in the reaction mixture 218 
were resolved by 20 % polyacrylamide–7 M urea gel electrophoresis before staining 219 
with Stains-All (Sigma–Aldrich). Color images obtained by scanning the stained gels 220 
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were converted to grey-scale images prior to quantification by Image J 221 
(http://imageJ.nih.gov/ij/). The Stains-All-based quantification method was used 222 
previously to assess the amount of RNA with similar lengths (58). 223 
In vitro SUMOylation assay 224 
The SUMOylated 3D proteins were produced by introducing pGEX-6p-3D into 225 
Escherichia coli (E.coli) BL21 (DE3) harboring pSUMO-1-Strep by electroporation. 226 
Strains were grown under selective pressure at 50 mg/L ampicillin and 25 mg/L 227 
streptomycin for co-expressing the two plasmids. The bacterial strains were cultured, 228 
and the protein was purified as previously described in the purification of 3D (53, 59), 229 
except that cell lysates were first loaded on GSTrap HP column (GE Healthcare, 230 
Waukesha, WI, USA). Subsequently, the eluted fractions were passed through 231 
StrepTrap HP column (GE Healthcare, Waukesha, WI, USA). After the two steps of 232 
enrichment, the extractions were separated by anion exchange and size exclusion 233 
chromatography for further purification (55). The collected fractions were 234 
electrophoresed on SDS-polyacrylamide gel (SDS-PAGE) detected by Coomassie 235 
blue staining or immunoblotting using Bio-Rad Imaging System. The immunoblot 236 
analysis was performed as previously described (45). 237 
SUMOylation and Ubiquitination assays 238 
SUMOylation and ubiquitination assays were performed with Dynabeads protein G 239 
(Life Technology, Grand Island, NY) for immunoprecipitation (IP). 293T cells were 240 
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cotransfected with indicated plasmids using calcium phosphate reagents of ProFection 241 
(Promega, Southampton, UK). For the assay of ubiquitination, 30 h post-transfection，242 
cells were lysed with western and IP lysis buffer plus complete protease inhibitors 243 
according to the manufacturer's instructions. For the SUMOylation assay, after 30 h of 244 
transfection, cells were harvested and lysed with western and IP lysis buffer plus 245 
complete protease inhibitors and 20 mM NEM. The lysates were centrifuged at 246 
16,000 g at 4 °C for 10 min. According to the protocol, 10 µg of corresponding 247 
antibody was incubated with 50 µL of protein G Dynabeads for 20 min before 248 
incubation with the supernatants of the cell lysis for 25 min. Following several washes 249 
with PBST (PBS with 0.02 % Tween-20), the complexes were boiled with 250 
electrophoresis sample buffer, followed by immunoblot (IB) analysis with indicated 251 
antibodies as previously described (45, 52). 252 
In assays involved EV71 infection, cells were cultured on 100-mm dishes. At 24 h 253 
post-transfection, 293T cells were infected with EV71 at an MOI of 10 for 18 h before 254 
harvesting. For the infection of RD, cells were lysed with RIPA lysis buffer after 255 
infection with EV71 at an MOI of 10 for 8 h. The supernatants were collected for IP 256 
as describe above. 257 
CHX chase analysis  258 
The CHX chase experiment was performed as described in Bio-protocol (60). Cells 259 
were seeded on 35 mm culture dishes at a density of 6 × 106 cells. Cells were 260 
transfected with Flag-3D and its mutant Flag-K159R/L150A/D151A/L152A. After 24 261 
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h, cells were treated with 100 µg/mL of CHX dissolved in DMSO in the presence or 262 
absence of 20 µM MG132. Cells were then collected at different time points and 263 
subjected to immunoblots. The quantification of protein levels was analyzed by Image 264 
J software.  265 
Statistical analysis 266 
Each of the experiment was repeated at least three times. Data from viral titer, one 267 
step growth curve, primer-dependent polymerase assays and CHX chase are presented 268 
as the mean ± standard deviation. Student’s t-test was used to determine the statistical 269 
significance between different tests, with significance defined as P < 0.05 or P < 0.01. 270 
Results 271 
3D polymerase is SUMOylated during EV71 infection 272 
SUMOylation is one of the post-translational modifications (PTMs) that play critical 273 
roles in diverse biological processes. However, little is known concerning how host 274 
PTM systems interact with enteroviruses 71. Online prediction suggested that EV71 275 
3D polymerase may bear SUMOylation sites. Herein, we performed experiments to 276 
investigate the SUMOylation of 3D during EV71 infection. RD cells infected with 277 
EV71 were harvested at 8 h post-infection before immunoprecipitating with an 278 
anti-3D antibody. Structural proteins VP1 and 3D polymerase of EV71 were detected 279 
in cell lysates, and the anti-3D antibody was able to detect 3D and its precursors 280 
3BCD and 3CD (Fig. 1B). SUMOylation and ubiquitination of 3D were detected by 281 
 o
n
 M
arch 5, 2020 at ST G
EO
RG
E'S LIBRARY
http://jvi.asm.org/
D
ow
nloaded from
 
16 
 
anti-SUMO-1 antibody and anti-Ub antibody (Fig. 1A). Notably, IP by anti-3D 282 
antibody could obtain 3D, 3CD, and 3BCD complexes, whereas 3C was proven to be 283 
SUMOylated, bands detected by anti-SUMO-1 antibody might be a mixture of 3D 284 
SUMOylation, 3CD SUMOylation and 3BCD SUMOylation. Anti-3C antibody only 285 
detected protein 3CD (about 73 kDa), anti-3D antibody detected both 3CD and 286 
SUMOylated 3D, and anti-SUMO-1 antibody detected SUMOylated bands (Fig. 1A). 287 
The bands detected by anti-3C antibody was different from that by anti-SUMO-1 288 
antibody or by anti-3D antibody, excluding the influence of 3CD and 3BCD 289 
SUMOylation (Fig. 1A). The SUMOylated 3Dpol was depicted by asterisks in the 290 
western blot detected by IP anti-3D followed by anti-SUMO-1 and anti-3D. The result 291 
of anti-SUMO-1 antibody showed one more SUMOylated band than that of anti-3D 292 
antibody, and this might be due to the antigenic epitope limitation of anti-3D antibody. 293 
Altogether, these results confirmed that EV71 3D could be SUMOylated during 294 
infection.  295 
EV71 3D is modified by SUMO-1 and 3 296 
We then performed experiments to confirm the SUMOylation of EV71 3D. 297 
SUMOylation is reversible by SENPs, which could be irreversibly inhibited by NEM; 298 
hence, the successful detection of this modification relies on the addition of NEM in 299 
the lysis buffer. We designed two experiments (Fig. 2A and 2B). Flag-3D, 300 
HA-SUMO-1, and Myc-Ubc9 (SUMO E2-conjugating enzyme) were overexpressed 301 
in 293T cells. At 30 h post-transfection, the cells were subjected to 302 
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immunoprecipitation with anti-Flag antibody. Higher molecular weights bands above 303 
unmodified 3D (~52 kD) ranging within 80–130 kD were detected by an 304 
anti-SUMO-1 or anti-HA antibody in the presence of NEM (Fig. 2A). The basal 305 
SUMO-1 moiety of 3D was removed when co-expressed with SENP-1 (Fig. 2B). For 306 
further verification, we performed co-immunoprecipitation experiment to study the 307 
relationship between 3D and Ubc9 with an anti-Flag antibody. The result showed that 308 
the SUMO-conjugating enzyme Ubc9 was present in the immunoprecipitated 309 
complex (Fig. 2C), indicating that 3D could interact with Ubc9. Furthermore, when 310 
3D was co-expressed with SUMO-1, 2, and 3 in 293T cells, 3D was preferentially 311 
modified by SUMO-1 and 3 in poly-SUMO chain conjugation, which could be 312 
deSUMOylated by SENP-1 (Fig. 2D).  313 
K159 and L150/D151/L152 are responsible for the SUMOylation of EV71 3D  314 
SUMO-1 conjugation has been reported to bind virtually to target proteins to regulate 315 
physiological processes, whereas SUMO-2 and 3 are more widely expressed as free 316 
non-conjugated forms, which are available for stress responses (22, 61). 317 
Unconjugated pool of SUMO-1 is lower than that of SUMO-2 and 3 (62), therefore 318 
our study focused on SUMO-1 modification. Bioinformatics analysis by SUMOplot 319 
Analysis Program predicted that several lysine residues in 3D may be modified by 320 
SUMO. K159, K376, and K427 of 3D following the consensus motif of ψ-K-X-D/E 321 
are the top three lysine residues on the list (Fig. 4A). K323 fits the inverted 322 
SUMOylation consensus motif E/D-x-K-ψ (Fig. 4A). The four lysine residues were 323 
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mutated to arginines to create mutants K159R, K376R, K427R and K323R. 3D and its 324 
mutants were co-expressed with SUMO-1 and Ubc9 in 293T cells to perform 325 
SUMOylation assays. Immunoprecipitation experiments indicated that the K323R, 326 
K376R, and K427R mutants had no obvious effect on SUMO-1 reduction, whereas 327 
K159R largely abolished the larger migration bands above 90 kD (Fig. 3A). These 328 
results also indicated that there are likely to be more than one site existed besides 329 
K159, which could be modified.  330 
As depicted above, SIMs are featured by hydrophobic amino acid cores flanked by 331 
acidic residues (V/I)(V/I)(D/E)(V/I/L)(T/D/E) and (V/I)(V/I)(V/I/L)(V/I/L)(D/E) (14, 332 
17). We created three mutants of 3D, namely, 150-152 SIM and 317-319 SIM which 333 
were created through inspecting 3D amino acid sequence, and 263-265 SIM which 334 
was predicted by SUMO-binding motif online prediction website (GPS-SBM) (Fig. 335 
4A) (63). Three alanines were introduced to substitute the LDL, VSL, and IDL of the 336 
SIMs to create the mutants. Fig. 3B shows that the band modified by SUMO-1 around 337 
80 kDa was considerably decreased in 150-152 SIM, whereas 263-265 SIM 338 
maintained almost the same bands as the wild-type 3D. 317-319 SIM completely 339 
attenuated the modified bands which was likely due to protein reduction in lysis. 340 
Considering the characteristics of the mutants, we constructed a mutant 341 
K159R/150-152 SIM by combining the mutation of K159R and 150-152 SIM. This 342 
mutant had remarkably decreased SUMO-1 modification in comparison with 3D or 343 
K159R, and 150-152 SIM (Fig. 3C). In the assay of SUMO-3, K159R lost the bands 344 
above 90 kDa, and K159R/150-152 SIM almost lost the SUMOylation totally, which 345 
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were similar to those in SUMO-1 (Fig. 3D). These results indicated that SUMO-3 346 
modification of 3D shares the same sites with SUMO-1. Furthermore, single mutation 347 
on K159 resulted in the reduction of higher bands but not the band around 80 kDa in 348 
the assay with both SUMO-1 and SUMO-3 (Fig. 3C, 3D), indicating that position 159 349 
was first modified by SUMO-3 and subsequently by SUMO-1 into a 350 
poly-SUMOylated chains. These results were observed because SUMO-1 could not 351 
be elongated and always acts as a terminator of ploy-SUMO chains (6, 7). In 352 
conclusion, K159 and L150/D151/L152 may be responsible for the SUMOylation of 353 
EV71 3D. 354 
Mutations of SUMOylation sites impair 3D polymerase activity and virus 355 
replication. 356 
Among the two SUMOylation sites in 3D, K159 is a highly conserved active site 357 
residue in RdRp motif F and within hydrogen-bonding distances to the edge of the 358 
nascent base pair of the RdRp elongation complex, while the 150-152 site is on the 359 
surface of 3D and does not directly participate in either RNA binding, NTP entry, and 360 
catalysis (Fig. 4B) (56). With an aim to assess the relevance of both SUMOylation 361 
sites to the polymerase function, we conducted primer-dependent polymerase assays 362 
(58, 64) for wild-type (WT) 3D and the K159R, K159A, and L150A/D151A mutants. 363 
With the usage of the T33/P10 RNA construct and GTP/ATP as the only substrates, 364 
the 10-nucleotide primer (P10) was expected to elongate by four nucleotides, 365 
producing a 14-nucleotide product (58). For the WT enzyme, the majority of the 366 
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primer was converted to the product within 60-min incubation time (Fig. 4C, 4D). The 367 
K159R mutant enzyme exhibited similar high conversion yield, while the K159A and 368 
L150A/D151A mutants had obviously lower yield with only 40% of primer converted 369 
judged by band intensity (Fig. 4C, 4D). These data in general suggest that both 370 
SUMOylation sites in 3D may modulate EV71 polymerase activity, despite their 371 
differences in structural properties based on available crystallographic data (56, 64). 372 
To assess the effect of 3D SUMOylation sites on EV71 replication, we constructed 373 
the IF-K159R and IF-K159R/150-152 SIM recombinant viruses. Unfortunately, both 374 
recombinant viruses were unable to be rescued. However, transfection of WT 3D 375 
protein and K159R recombinant RNA resulted in the rescue of wild-type virus. A 376 
L150A/D151A mutant was constructed to map the critical region. Since the 377 
L150A/D151A mutant can largely decrease the SUMO-1 modification (Fig. 3C), we 378 
also tested the IF-L150A/D151A recombinant virus. As shown in Figure 4E the 379 
growth curve of this recombinant virus was significant lower than that of wild-type 380 
virus. Therefore, the lower titer of IF-L150A/D151A was likely due to the decreased 381 
enzyme activity or/and lack of SUMOylation.  382 
3D protein is SUMOylated in vitro  383 
SUMOylation is a process of enzyme-catalyzed reactions. Two-component vector 384 
systems carrying SAE1, SAE2, Ubc9, SUMO-1 and the target protein in E.coli were 385 
used to generate SUMOylated proteins in vitro (55). In the present study, we used the 386 
method by transforming E. coli with pSUMO-1-Strep and pGEX-6p-3D to produce 387 
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SUMOylated proteins (Fig. 5A). SUMO-1 modified proteins were confirmed by 388 
SDS-PAGE and immunoblot. Under IPTG induction, the results of Coomassie blue 389 
staining and immunoblot showed that BL21 (pSUMO-1-Strep and pGEX-6p-3D) 390 
strains not only expressed 3D-GST but also 3D-GST-SUMO-1s (Fig. 5B, Lanes 3 and 391 
4). By contrast, BL21 (pGEX-6p-3D) only produced 3D-GST (Fig. 5B, Lane 1 and 6). 392 
After induction, the cell lysates of BL21 (pSUMO-1-Strep and pGEX-6p-3D) strains 393 
were subjected to subsequent GST and Strep affinity chromatography. The collected 394 
protein samples were resolved by SDS-PAGE and visualized by Coomassie blue 395 
staining (Fig. 5C). SUMOylated 3D was verified by immunoblotting with the anti-3D 396 
or anti-SUMO-1 antibody (Fig. 5D). These results indicate that EV71 3D can be 397 
modified by SUMO-1 in vitro. 398 
3D is ubiquitinated in a SUMOylation-dependent manner 399 
The ubiquitin–proteasome system (UPS) is required for the effective replication of 400 
both coxsackievirus B3 (CVB3) (65) and EV71 (66). Since SUMOylation can 401 
interplay with ubiquitination in many viral proteins, we determined whether EV71 3D 402 
is ubiquitinated. Flag-3D and K159R/150-152 SIM were co-expressed with HA-Ub in 403 
293T cells for ubiquitination assay (Fig. 6A). The cell lysates were subjected to 404 
immunoprecipitation with the anti-Flag antibody. Immunoblot by the anti-HA 405 
antibody showed that 3D could be poly-ubiquitinated (polyUb), whereas the mutant 406 
K159R/150-152 SIM almost lost this modification. 407 
The above experiments implied that ubiquitination and SUMOylation of 3D may 408 
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share the same lysine residues and 3D ubiquitination was SUMOylation related. To 409 
determine the association between the two modifications, SENP-1 and lysine-less 410 
ubiquitin Ub (KO) were introduced into 3D SUMOylation and ubiquitination 411 
experiments. Ub (KO) terminates ubiquitin chain, and it was created by replacing all 412 
lysines with arginines. Ub (KO) had dose-dependent effect on the ubiquitin system 413 
when Ub (KO) was overexpressed to compete with the endogenous ubiquitin (67). In 414 
our study, 3D ubiquitination was increased when Ub was co-expressed with SUMO 415 
and Ubc9 (Fig. 6B). Co-expression of SENP-1 decreased both 3D SUMOylation and 416 
ubiquitination, which was in accordance with the results of the mutant 417 
K159R/150-152SIM. The co-expression of Ub (KO) resulted in the reduction of 3D 418 
ubiquitination, but it hardly had any effect on 3D. 419 
We further investigated whether 3D ubiquitination level could be altered according to 420 
the gradient expression of SENP-1 or SUMO-1 in 293T cells. The ubiquitination level 421 
was enhanced when the SUMOylation of 3D was increased (Fig. 6C). On the contrary, 422 
the increased expression of SENP-1 gradually reduced the amount of ubiquitin 423 
conjugated on 3D (Fig. 6D). Taken together, these data imply that the two 424 
modifications sequentially occur, with ubiquitination being highly 425 
SUMOylation-dependent. 426 
SUMO-1 modification enhances the stability of 3D  427 
Normally, the polyUbs are primarily linked through K48 or K63 to play diverse roles 428 
in regulating cellular activities, which account for 52 % and 38 % of all ubiquitination 429 
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events, respectively (68). K48-linked ubiquitination chains are involved in 430 
proteasomal degradation, whereas K63-linked ubiquitination is a docking site for 431 
mediating protein–protein interactions or conformational changes (69). To explore 432 
which kind of polyUb 3D is linked and whether 3D is degraded, we transfected 3D 433 
and K159R/150-152 SIM together with HA-K48-Ub or HA-K63-Ub to perform the 434 
ubiquitination assay. 3D was specifically modified by K63-linked ubiquitin, whereas 435 
the K159R/150-152 SIM significantly reduced the conjugation (Fig. 7A). Noticeably, 436 
no degradation of 3D was observed in the assay (Fig. 7A).  437 
CHX chase experiments were then carried out to determine the stability difference 438 
between 3D and K159R/150-152 SIM. 3D exhibited longer half-life than 439 
K159R/150-152 SIM, and the MG132 treatment attenuated K159R/150-152 SIM 440 
degradation (Fig. 7B, 7C). These results imply that SUMOylation-related K63-linked 441 
ubiquitination may stabilize 3D. 442 
Elevated SUMO-1 expression level increases EV71 replication 443 
To analyze the effects of SUMO-1 overexpression on virus production, SUMO-1 and 444 
Ubc9 were transiently transfected into 293T cells. The cells were subsequently 445 
infected with EV71 for 18 h. The SUMOylation and ubiquitination levels of viral 3D 446 
increased in the condition of SUMO-1 overexpression (Fig. 8A). 3CD protein was 447 
detected by anti-3C antibody. These results implied that though IP by an anti-3D 448 
antibody could co-immunoprecipitated 3D, 3CD, and 3BCD, while data from the 449 
anti-SUMO-1 antibody indicated that 3D was indeed modified by SUMO-1. The 450 
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expression of viral 3D and VP1 were increased when SUMOylation level was 451 
enhanced (Fig. 8B). The titer of EV71 produced from SUMOylation-increased 293T 452 
cells was higher than that from 293T transfected with the empty vector (Fig. 8C). 453 
Collectively, these results indicated that elevation of the global cell SUMOylation 454 
increased both SUMOylation and ubiquitination level of 3D, which augmented 3D 455 
expression and consequently enhanced viral replication.  456 
Discussion 457 
A number of viral proteins have been reported to be modified by SUMO moieties (22, 458 
62). However, the knowledge concerning SUMOylation in enteroviruses is limited. 459 
Only EV71 3C protease is SUMOylated, while coxsackievirus B5 is involved in the 460 
host cell SUMOylation system in the Picornaviridae family (38, 62, 70). Current 461 
understanding of viral polymerases SUMOylation is limited to RdRp of Turnip 462 
Mosaic Virus (71), DNA polymerase subunit UL44 of HCMV (25), nonstructural 463 
protein 5 (NS5) of dengue virus (72), and polymerase basic protein PB1 of influenza 464 
virus (30). In the currently study, we reveal that the 3D protein of EV71, a 465 
RNA-dependent RNA polymerase, is SUMOylated. We found that EV71 3D 466 
polymerase is modified by SUMO-1 both in vivo and in vitro and that 3D is stabilized 467 
by SUMOylation-related ubiquitination. K159 and L150/D151/L152 are responsible 468 
for 3D SUMOylation. Mutations of SUMOylation sites impaired 3D polymerase 469 
activity and virus replication. Moreover, elevated SUMOylation level during EV71 470 
infection resulted in promoted 3D stability which enhanced viral replication. We 471 
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propose that SUMOlyation at specific 3D sites help maintain the cellular level of 3D 472 
protein and the corresponding de-SUMOlyation may be necessary for 3D to resume 473 
its polymerase activity. The 3D polymerase function may be only required when it is 474 
responsible for the RNA genome replication which is SUMOylation free. These 475 
findings implicate that EV71 exploits host proteins for its effective infection and that 476 
the SUMO system is likely to be a putative antiviral target.  477 
Online prediction indicated that 3D is bearing both covalent and non-covalent sites for 478 
SUMOylation. According to the predictions, K159, K427, and K376 are on the top 479 
three of the list following the pattern of ψ-K-X-D/E motif 480 
(http://www.abgent.com/sumoplot.html), while V263/S264/L265 is the putative 481 
SUMO-interacting motif (SIM) (63). In our study, K159 and L150/D151/L152 as SIM 482 
are proven to be the SUMOylation sites, while K159 follows the classic consensus 483 
motif of ψ-K-X-D/E and is the major site for SUMO-1 modification (Fig. 3A). 484 
However, although L150/D151/L152 is not within the predicted SUMOylation sites of 485 
3D, they have been proven to be a SIM in our study. Additionally, the inverted 486 
consensus motif E/D-X-K-ψ worked for EV71 3C but not for 3D (38). In fact, the 487 
bioinformatic prediction software is based on the calculation of the reported 488 
SUMOylation site, and some unknown limitations may exist. Therefore, there may be 489 
SUMOylation sites that cannot be predicted by bioinformatic software. For instance, 490 
mutation of the predicted SUMOylation sites in human Cytomegalovirus DNA 491 
polymerase processivity factor UL44 hardly attenuates the modification (25). Herein, 492 
our findings of L150/D151/L152 as SIM site may expand the data pool for developing 493 
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higher confidences algorithm.  494 
Normally, the interplay between SUMOylation and ubiquitination often involves the 495 
stability of the target protein. (73). SUMOylation and K48-linked ubiquitination of 496 
IRF3 share the same lysine residues and the two processes are competitive, indicating 497 
that SUMOylation of IRF3 stabilizes the protein by antagonizing ubiquitination (51). 498 
SUMOylation of EV71 3C protease shares the same K52 with its ubiquitination, and 499 
consequently enhances ubiquitination which leads to the degradation of 3C (38). 500 
Other study showed how the two PTMs cooperatively stabilized target proteins in 501 
various ways. For instance, the E3 protein of vaccinia virus is modified by both 502 
SUMOylation and ubiquitination. Wild-type E3 exhibited longer half-life than its SIM 503 
mutant. It was speculated that the different stabilities observed between the wild-type 504 
E3 and the SIM-mutant were due to the longer ubiquitin chains conjugated on 505 
SIM-mutant (74). SUMOylation stabilizes dengue virus NS5 from proteasome 506 
degradation which supports virus replication (72). SUMO-1 stabilizes phosducin, and 507 
the authors inferred that SUMO moieties conjugated on phosducin may mask the 508 
region recognized by ubiquitin-proteasome pathway (75). Following gradient 509 
overexpression of SUMO-1 and Ubc9 or SENP-1 with 3D, the results showed that the 510 
level of ubiquitination was highly dependent on SUMOylation. Moreover, when Ub 511 
was substituted with Ub (KO), 3D ubiquitination was reduced, although it hardly had 512 
any effect on 3D SUMOylation. Taken together, these results implied that 513 
poly-SUMO chain likely act as a signal for 3D ubiquitination. In such case, ubiquitin 514 
might be hybridized with poly-SUMO chains or be conjugated on the exposed internal 515 
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residues of 3D due to the conformational change induced by SUMOylation. The 516 
importance of UPS during replication of both coxsackievirus B3 (CVB3) and EV71 517 
may rely on 3D SUMOylation (65, 66). We found that the degradation of 3D by 518 
K63-linked ubiquitination was not observed and that wild-type 3D showed longer 519 
half-life than the SUMOylation-deficient mutant K159R/150-152 SIM. The 520 
K63-linked poly-ubiquitination generally has non-proteolytic cellular functions, 521 
including DNA damage repair, stress responses, and inflammatory pathways (76). 522 
Taken together, SUMO-moieties conjugated on 3D act as a signal for K63-linked 523 
ubiquitination which cooperatively stabilizes 3D.  524 
K159 is within RdRp catalytic motif F and is highly conserved in positive-strand 525 
RNA viruses (77). Structurally, this residue is located in the polymerase active site 526 
and within hydrogen-bonding distance to the nascent base pair (Fig. 4B) (56, 64, 78). 527 
Therefore, it is not surprising that the K159A mutation reduces in vitro polymerase 528 
activity (Fig. 4C, 4D). The K159R mutation, however, retained WT level polymerase 529 
activity in our test but the corresponding recombinant virus was not viable. Despite 530 
being an amino acid with a basic side chain, the arginine may be not ideal to replace 531 
the native lysine at this critical position. Due to its critical roles in polymerase 532 
catalysis, we tend to believe that the defects in polymerase catalysis (although not 533 
clarified in our in vitro assays) rather than the loss of SUMOlyation property accounts 534 
for the inviability of the recombinant virus IF-K159R. Compared to K159, the 535 
150-152 SIM is moderately conserved only in enteroviruses and is located near the 536 
polymerase surface (Fig. 4B), and therefore it is unlikely to play major roles in 537 
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polymerase catalysis. Although the in vitro enzyme activity of L150A/D151A was 538 
lower than that of 3D, the recombinant virus IF-L150A/D151A was successfully 539 
rescued. The fact that the titer of IF-L150A/D151A recombinant virus was lower than 540 
that of the WT EV71 was likely due to the reduced enzyme activity, or/and the 541 
impairment of SUMOylation. To reinforce the deduction, we adopted a method by 542 
overexpressing SUMO-1 to determine how SUMOylation system could affect EV71 543 
infection. EV71 infection in SUMOylation elevated 293T cells showed that more 544 
SUMO-1 led to higher ubiquitination of 3D which increased virus production 545 
compared with the cells transfected with empty vector. It is reported that EV71 3C 546 
K52R SUMOylation deficient virus showed elevated virus titer compared to wild-type 547 
virus (38). The increased titer of EV71 from SUMO-1 overexpressed cells was likely 548 
due to higher SUMOylation and ubiquitination on 3D, which may eventually stabilize 549 
3D and the augmented polymerases promoted EV71 replication. Other than the results 550 
from EV71 3C SUMOylation, the increased gobal SUMOylation level is beneficial 551 
for EV71 replication. Although 3C and 3D SUMOylation have opposite consequences 552 
during EV71 replication, the influence of 3D SUMOylation is greater than that of 3C. 553 
As a polymerase, any modification on 3D may affect virus replication, and in the case 554 
of SUMOylation, the impact is favorable for the virus replication. These results 555 
suggested that EV71 may exploit the SUMOylation-related ubiquitination to facilitate 556 
its replication by protecting the 3D polymerase.  557 
Timely turning on and off of SUMO signaling on viral proteins is important for virus 558 
replication (32). Given that 3D is a RdRp, the maintenance of an appropriate level of 559 
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RdRp in infected cells is crucial for viral growth, as lower amount of RdRp may be 560 
beneficial for the virus to escape host immune systems (79, 80). It is worthy to note 561 
that the SUMOylation of 3D and the RNA synthesis by 3D may well be two processes 562 
with relative independence. Based on the chemical nature of polymerase catalysis and 563 
the SUMOlyation process, at least the covalent SUMOlyation at K159 is not 564 
compatible with polymerase catalysis. We propose that SUMOlyation at specific 3D 565 
sites help maintain the cellular level of 3D protein and the corresponding 566 
de-SUMOlyation may be necessary for 3D to resume its polymerase activity, in 567 
particular for the critical site of K159. In summary, our findings showed that 568 
ubiquitination of EV71 3D is SUMOylation-dependent. EV71 may exploit the 569 
crosstalk of SUMOylation and ubiquitination to stabilize the 3D polymerase and 570 
enhance viral replication, which may provide new insights on antivirus by targeting 571 
the SUMOylation of EV71 3D. 572 
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Figure Legends 802 
Figure 1. EV71 3D is SUMOylated during infection. 1×107 RD cells were infected with EV71 virus 803 
(MOI = 10) and harvested at 8 h post-infection before immunoprecipitation with an anti-3D antibody. 804 
Immunoprecipitation (IP) and immunoblot (IB) analyses were performed with the indicated antibodies 805 
in the presence of NEM. (A)  Immunoblot detected by anti-SUMO-1, anti-Ub, anti-3C and anti-3D 806 
antibodies during EV71 infection after immunoprecipitation by the anti-3D antibody. (B) Immunoblot 807 
analysis of the cell lysis during infection. Anti-VP1, anti-3D and anti-beta actin antibodies were used to 808 
detect the expression of VP1, 3D and beta-actin during infection. Lysis of RD cells without infection 809 
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was set as MOCK control. SUMO-1 modified 3D, ubiquitin modified 3D, and 3CD are depicted by 810 
asterisks, brackets, and arrows, respectively. 811 
Figure 2. EV71 3D is modified by SUMO-1 and 3. (A) SUMOylation of EV71 3D in the presence of 812 
NEM. 293T cells were transfected with Flag-3D, Myc-Ubc9, and HA-SUMO-1. Cells were lysed with 813 
or without the addition of NEM, which was added to a final concentration of 20 mM prepared in 814 
ethanol. Immunoprecipitation and immunoblot analysis were performed with the indicated antibodies 815 
for SUMOylation assay. (B) DeSUMOylation of 3D by SENP-1. 293T cells were transfected with 816 
Flag-3D, Myc-Ubc9, HA-SUMO-1, and V5-SENP-1. Immunoprecipitation and immunoblot analysis 817 
were performed with the indicated antibodies in the presence of NEM. (C) 3D interacted with Ubc9. 818 
293T cells were transfected with Flag-3D, Myc-Ubc9, or empty vector. Co-immunoprecipitation was 819 
performed with anti-flag or control mouse IgG; immunoblots were probed with the corresponding 820 
antibodies. (D) 3D was modified by SUMO-1 and 3. Flag-3D, Myc-Ubc9, HA-SUMO-1, HA-SUMO-2, 821 
and HA-SUMO-3 were overexpressed in 293T cells. Immunoprecipitation and immunoblot analysis 822 
were performed with the indicated antibodies in the presence of NEM. Molecular size markers are 823 
shown in kilodaltons (kDa). SUMO-1 modified Flag-3Ds are depicted by brackets. 824 
Figure 3. Identification of Lys159 and Leu150/Asp151/Leu152 as major SUMOylation sites. (A) 825 
SUMOylation assay of 3D and its single site mutants based on the canonical consensus motif. The 826 
lysine residue at 159, 323, 376, and 427 were replaced by arginine to create K159R, K323R, K376R 827 
and K427R. (B) SUMOylation assay of 3D and its SIM mutants. The Leu150/Asp151/Leu152, 828 
Val263/Ser264/Leu265, and Ile317/Asp318/Leu319 were mutated into three consecutive alanine 829 
residues, namely, 150-152 SIM, 263-265 SIM, and 317-319 SIM. (C) SUMOylation assay by SUMO-1 830 
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of 3D and its selected mutants. K159R/150-152 SIM was generated by mutating Lys159 into Arg159 831 
and Leu150/Asp151/Leu152 into Ala150/Ala151/Ala152. L150A/D151A was created by mutating 832 
Leu150/Asp151 into Ala150/Ala151. (D) SUMOylation assay by SUMO-3 of 3D and its selected 833 
mutants. Immunoprecipitation and immunoblot analysis were performed with the indicated antibodies 834 
in the presence of NEM. Molecular size markers are shown in kilodaltons. SUMO-1 modified 835 
Flag-3Ds are depicted by brackets. 836 
Figure 4. Assessments of the relevance of the 3D SUMOylation sites to polymerase activity and 837 
virus replication. (A) Schematic representation of the potential lysine residues and SIMs in 838 
enterovirus polymerase by sequence alignment. Polyprotein sequences of Enterovirus 71 (GenBank: 839 
AB204852.1), Coxsackievirus A16 (GenBank: AY790926.1), Poliovirus (GenBank: KT353719.1), 840 
Coxsackievirus A9 (Genebank: D00627.1), Coxsackievirus B3 (GenBank: M16572.1) were used in the 841 
alignment. (a) The putative sites of 150-152 SIM and K159. (b) The putative sites of 263-265 SIM. (c) 842 
The putative sites of 317-319 SIM and K323. (d) The putative sites of K376 and K427. The SIM motifs 843 
are highlighted in red and the lysine residues are in green. (B) An EV71 3D elongation complex crystal 844 
structure with a closed conformation active site (PDB entry 5F8J) depicting structural features of the 845 
SUMOylation sites. The polymerase adopts an encircled human right hand architecture with thumb (in 846 
slate), palm (in grey), and fingers domains surrounding the active site. The fingers domain is further 847 
divided into index (in green), middle (in orange), ring (in yellow), and pinky (pink) finger subdomains. 848 
The template (in cyan) and product (in green) RNA duplex are shown in a ladder format with the active 849 
site nucleotide pair shown as thick sticks. The K159 (side chain in spheres) is within the ring finger 850 
subdomain and is an active site residue interacting with the nascent base pair, while the L150 and D151 851 
(side chains in spheres) are on the polymerase surface, being part of the pinky finger. (C, D) In vitro 852 
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polymerase activity of 3D and its mutants K159R, K159A and L150A/D151A. The time-dependent 853 
conversion of the primer P10 to the 14-mer product was compared among WT and three mutant 854 
enzymes. Values and error bars shown in panel C were taken from three independent experiments with 855 
a representative gels shown in panel B (Student’s t-test, *P < 0.05). (E) Growth curves of EV71 and its 856 
mutant IF-L150A/D151A in RD cells. 5 × 105 RD cells were infected with the wild-type EV71 virus or 857 
its variant IF-150A/D151A (MOI = 10), and harvested at the indicated times post-infection. Viral 858 
growth curves were generated by plotting virus titer (expressed as TCID50/ml) against time. 859 
Experiments were carried out in triplicate. Significant differences were determined using the Student’s 860 
t-test (*P < 0.01). 861 
Figure 5. In vitro SUMO-1 modification of 3D. (A) Schemes of the gene arrangement of 862 
pSUMO-1-Step and pGEX-6p-3D. pSUMO-1-Strep carrying ubc9 (SUMO-conjugating enzyme E2), 863 
SAE1, and SAE2 (SUMO-activating enzyme), and SUMO-1 (tagged at the N-terminus with Strep-tag) 864 
was used for the expression of the enzymes required for SUMOylation. pGEX-6p-1 carrying 3D was 865 
used for the expression of GST-taged 3D. (B) Escherichia coli BL21 (pGEX-6p-3D) and BL21 866 
(pSUMO-1-Strep and pGEX-6p-1) were used to produce GST-3D and GST-3D-SUMO-1. The 867 
supernatants of the two strains were analyzed by Coomassie blue staining (Lanes 1–3) and 868 
immunoblotting (Lanes 4–6) with the anti-3D antibody under the induction of IPTG (500 µM) at 25 °C 869 
for 10 h. BL21 (pSUMO-1-Strep and pGEX-6p-1) without IPTG induction was used as the control 870 
(Lanes 2 and 5). (C, D) Cell lysates of E. coli BL21 (pSUMO-1-Strep and pGEX-6p-1) were subjected 871 
to subsequent GST and Strep affinity purification to separate SUMOylated proteins. Fractions during 872 
purification of SUMOylated proteins were analyzed by SDS-PAGE and subsequent Coomassie blue 873 
staining (C) and immunoblotting (D) by anti-3D and anti-SUMO-1 antibodies. M, marker. Lanes 1–6 874 
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of C: crude lysate supernatants, GST column flow through, GST column eluted fraction, dialyzed 875 
elution fractions, Strep column flow through, Strep column eluted fraction. Lanes 1–5 of D: crude 876 
lysate supernatants, GST column flow through, GST column eluted fraction, Strep column flow 877 
through, Strep column eluted fraction. Molecular size markers are shown in kilodaltons. SUMO-1 878 
modified and unmodified GST-3Ds are depicted by brackets and arrows, respectively. 879 
Figure 6. Conjugation of ubiquitin to 3D based on its SUMOylation levels. (A) Ubiquitination 880 
assay of 3D and K159R/150-152 SIM. 293T cells were transfected with the indicated constructs. 881 
Immunoprecipitation and immunoblot analysis were performed with the indicated antibodies for 882 
ubiquitination assay. (B) Ubiquitination and SUMOylation assay of 3D. 293T cells were transfected 883 
with the indicated constructs. In particular, HA-UB-KO was co-expressed to remove endogenous 884 
ubiquitin, while V5-SENP-1 was co-expressed for deSUMOylation. Immunoprecipitation and 885 
immunoblot analysis were performed with the indicated antibodies. (C, D) SUMOylation affected the 886 
ubiquitination of 3D in a dose-dependent manner. 293T cells transfected with 2 µg of Flag-3D and 2 µg 887 
of HA-Ub or Myc-Ubc9 (0.5, 1, 1.5, and 2 µg) or Myc-SUMO-1 (0.5, 1, 1.5, or 2 µg) or V5-SENP-1 888 
(0.5, 1, 1.5, and 2 µg) in 60 mm dishes. The empty vector was used to adjust the total DNA. 889 
Immunoprecipitation and immunoblot analysis were performed with the indicated antibodies. 890 
Molecular size markers are shown in kilodaltons. SUMO-1 and ubiquitin modified 3Ds are depicted by 891 
brackets. 892 
Figure 7. SUMOylation of 3D increased protein stability. (A) 3D was modified by K63-linked 893 
ubiquitin. Flag-3D or K159R/150-152 SIM and HA-K48-Ub or HA-K63-Ub were transfected into 894 
293T cells for ubiquitination assay. Immunoprecipitation and immunoblot analysis were performed 895 
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with the indicated antibodies. The ubiquitin modified 3Ds are depicted by brackets. (B, C) 896 
Cyclohexamide chase assay of 3D and K159R/150-152 SIM. 293T cells (1×105) were transfected with 897 
3D or K159R/150-152 SIM. After 24 h, cells were treated with 100 µg/mL of CHX for the indicated 898 
periods of time in the presence or absence of 20 µM MG132. Cell lysates were analyzed by 899 
immunoblotting with the anti-Flag antibody. 3D and its mutant bands were quantitated by Image J 900 
software. The amount of 3D and its mutant relative to levels in untreated cells was indicated at the 901 
bottom of the bands. The plot shows the half-lives of 3D and K159R/150-152 SIM from three 902 
independent experiments. Significant differences were determined using the Student’s t-test (*P < 903 
0.01). 904 
. 905 
Figure 8. SUMO-1 modification promoted EV71 replication. 7×106 293T cells were transfected with 906 
HA-SUMO-1, Myc-Ubc9 or empty vector in 100-mm dishes. At 24 h post-transfection, cells were 907 
infected with EV71 (MOI = 10) for 18 h. One of the dishes with no transfection was used as the control. 908 
Immunoprecipitation and immunoblot analysis were performed with the indicated antibodies. (A) 909 
SUMOylation and ubiquitination assay of 3D in SUMO-1 elevated cells after EV71 infection by 910 
immunoprecipitation. (B) Immunoblot analysis of the cell lysis during infection. Anti-VP1, anti-3D and 911 
anti-beta actin antibodies were used to detect the expression of VP1, 3D and beta-actin during infection.  912 
Anti-myc antibody was used to detect the expression of Ubc9. SUMO-1 and ubiquitin modified 3Ds 913 
are depicted by brackets. 3CD is showed by arrow. (C) Growth curves of EV71 produced from 914 
transfected 293T cells in RD cells. 293T cells were transfected with HA-SUMO-1, Myc-Ubc9 or empty 915 
vector for 24 h, followed by infection with EV71 at an MOI of 10 for 18 h. Cells were harvested at 916 
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indicated time of post-infection to plot the growth curves. Data is presented as the means ± standard 917 
deviations obtained from three independent experiments. Significant differences were determined using 918 
the Student’s t-test (*P < 0.01). 919 
 920 
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